found that an N‐glycosylated B7 homolog 3 protein (B7H3) is significantly correlated with poor prognoses in patients with triple‐negative breast cancer (TNBC), and they demonstrated that the aberrant core fucosylation of B7H3 suppresses anti‐tumor immune responses in patients with TNBC.22 The gene discussed is CD276; the disease is neoplasm.